Regular paper
Simultaneous determination of GTS-21 and its metabolite in rat plasma by high-performance liquid chromatography using solid-phase extraction

https://doi.org/10.1016/S0378-4347(96)00233-2Get rights and content

Abstract

It has been suggested that GTS-21 can improve the learning deficits and inhibit the neuro-degeneration in patients with Alzheimer's disease. This paper describes a reversed-phase high-performance liquid chromatographic assay with visible detection at 405 nm for determination of GTS-21 and its metabolite, 4-hydroxy-GTS-21 in rat plasma. The method uses solid-phase extraction with a Bond Elut C18 column. A quantitation limit of 1.0 ng/ml was achieved using 0.5 ml of rat plasma. In the validation study, the coefficients of variation and the relative errors of each compound were less than 10%. Also freeze-thaw and storage stability were confirmed. This method has proved to be applicable to the pharmacokinetic study of GTS-21 in rats.

References (4)

  • E.M. Meyer et al.

    Drug Dev. Res.

    (1994)
  • E.J. Martin et al.

    Drug Dev. Res.

    (1994)
There are more references available in the full text version of this article.

Cited by (0)

View full text
Copyright © 1996 Published by Elsevier B.V.